# ACS Dobfar  s.p.a. – FDA Inspection, Nov 8, 2018

Source: https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/78c1bc99-9573-4ac5-a2f5-085d101bc9d8
Source feed: FDA_Inspections

> FDA inspection 1074746 of ACS Dobfar  s.p.a., November 08, 2018. Classification: No Action Indicated (NAI). 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1074746
- Company Name: ACS Dobfar  s.p.a.
- Inspection Date: 2018-11-08
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 933850 - 2015-07-10](https://www.keypedia.com/records/fda_inspections/acs-dobfar-spa/eb2f6fb9-2233-461d-9ad5-3267285d632d)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/dawn-c-olenjack/b5a18d10-cd4b-405e-9016-8f5274a33000)

Company: https://www.keypedia.com/companies/acs-dobfar-spa/af738b5f-939d-467e-84f5-7ede8721f1cb

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c